Post transplant maintenance therapy with newly FDA-approved revumenib for high-risk KMT2Ar acute leukemiaOlayinka Okeleji, Irtiza Sheikh, David McCall et al.|Blood Advances|2025Cited by 4
Post-transplant maintenance with revumenib in children with HOX-driven AMLBranko Cuglievan, Ghayas C. Issa, Demetrios Petropoulos et al.|Blood|2025Cited by 2
Allogeneic Hematopoietic Stem Cell Transplant for an Unknown Inherited Bone Marrow Failure Syndrome With a Novel Compound Heterozygous MutationOlayinka Okeleji, Irtiza Sheikh, Sajad Khazal et al.|Pediatric Blood & Cancer|2025Cited by 0
Outcomes of stem cell transplantation in pediatric and adolescent/young adult patients with trisomy 21: A single-center experienceMaria Frost, Priti Tewari, Olayinka Okeleji et al.|Blood|2025Cited by 0
Positive outcomes associated with stem cell transplantation in pediatric/AYA patients who receive FLAG-IDA-venetoclax for high-risk AMLIrtiza Sheikh, Priti Tewari, Reeja Raj et al.|Blood|2025Cited by 0